Introduction of a Senate OTC monograph reform bill largely tracking a House discussion draft – including two-year market exclusivity for some products – provides “great encouragement” Congress this year will pass legislation to improve the FDA program, says the Consumer Healthcare Products Association.
The “Over-the-Counter Drug Safety, Innovation and Reform Act,” S.2315, like a discussion draft in the House, proposes streamlining...







